Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


03.09.2018

1 Ann Oncol
1 Ann Surg Oncol
7 BMC Cancer
1 Breast Cancer (Auckl)
2 Breast Cancer Res
9 Breast Cancer Res Treat
3 Cancer Lett
1 Cancer Res
3 Clin Breast Cancer
1 Clin Cancer Res
1 Clin Med Insights Oncol
1 Eur J Surg Oncol
1 Int J Cancer
1 Int J Oncol
1 Int J Radiat Oncol Biol Phys
1 J Clin Invest
1 Lancet Oncol
2 Mod Pathol
2 NPJ Breast Cancer
2 Oncogene
1 Oncol Rep
2 Oncology (Williston Park)
1 Pathology
5 PLoS One
6 Proc Natl Acad Sci U S A
4 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. CHEN X, Li Y, Ouyang T, Li J, et al
    Associations between RAD51D germline mutations and breast cancer risk and survival in BRCA1/2-negative breast cancers.
    Ann Oncol. 2018 Aug 27. pii: 5079839. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. THEOBALD KA, Susswein LR, Marshall ML, Roberts ME, et al
    Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis.
    Ann Surg Oncol. 2018 Aug 30. pii: 10.1245/s10434-018-6581.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. HEIL J, Sinn P, Richter H, Pfob A, et al
    RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial.
    BMC Cancer. 2018;18:851.
    PubMed     Text format     Abstract available

  4. ANWAR SL, Tampubolon G, Van Hemelrijck M, Hutajulu SH, et al
    Determinants of cancer screening awareness and participation among Indonesian women.
    BMC Cancer. 2018;18:208.
    PubMed     Text format     Abstract available

  5. SANKATSING VDV, Fracheboud J, de Munck L, Broeders MJM, et al
    Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening.
    BMC Cancer. 2018;18:256.
    PubMed     Text format     Abstract available

  6. KJALLQUIST U, Erlandsson R, Tobin NP, Alkodsi A, et al
    Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).
    BMC Cancer. 2018;18:174.
    PubMed     Text format     Abstract available

  7. WESTVIK AS, Weedon-Fekjaer H, Maehlen J, Liestol K, et al
    Evaluating different breast tumor progression models using screening data.
    BMC Cancer. 2018;18:209.
    PubMed     Text format     Abstract available

  8. NAAB TJ, Gautam A, Ricks-Santi L, Esnakula AK, et al
    MYC amplification in subtypes of breast cancers in African American women.
    BMC Cancer. 2018;18:274.
    PubMed     Text format     Abstract available

  9. MENSAH KB, Oosthuizen F, Bonsu AB
    Cancer awareness among community pharmacist: a systematic review.
    BMC Cancer. 2018;18:299.
    PubMed     Text format     Abstract available


    Breast Cancer (Auckl)

  10. HEUSER VD, Mansuri N, Mogg J, Kurki S, et al
    Formin Proteins FHOD1 and INF2 in Triple-Negative Breast Cancer: Association With Basal Markers and Functional Activities.
    Breast Cancer (Auckl). 2018;12:1178223418792247.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  11. DA CRUZ RS, Carney EJ, Clarke J, Cao H, et al
    Paternal malnutrition programs breast cancer risk and tumor metabolism in offspring.
    Breast Cancer Res. 2018;20:99.
    PubMed     Text format     Abstract available

  12. HUTCHESON IR, Knowlden JM, Hiscox SE, Barrow D, et al
    Correction to: Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
    Breast Cancer Res. 2018;20:98.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  13. YANG J, Lv Q
    Theoretical possibility of primary breast cancer originates from ectopic breast tissue in axillary lymph nodes.
    Breast Cancer Res Treat. 2018 Aug 27. pii: 10.1007/s10549-018-4926.
    PubMed     Text format    

  14. GOTO-YAMAGUCHI L, Yamamoto-Ibusuki M, Yamamoto Y, Fujiki Y, et al
    Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling.
    Breast Cancer Res Treat. 2018 Aug 27. pii: 10.1007/s10549-018-4933.
    PubMed     Text format     Abstract available

  15. FRONTERA ED, Khansa RM, Schalk DL, Leakan LE, et al
    IgA Fc-folate conjugate activates and recruits neutrophils to directly target triple-negative breast cancer cells.
    Breast Cancer Res Treat. 2018 Aug 28. pii: 10.1007/s10549-018-4941.
    PubMed     Text format     Abstract available

  16. NAROD SA, Giannakeas V, Sopik V
    Time to death in breast cancer patients as an indicator of treatment response.
    Breast Cancer Res Treat. 2018 Aug 30. pii: 10.1007/s10549-018-4935.
    PubMed     Text format     Abstract available

  17. SHEN S, Unger JM, Crew KD, Till C, et al
    Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
    Breast Cancer Res Treat. 2018 Aug 29. pii: 10.1007/s10549-018-4946.
    PubMed     Text format     Abstract available

  18. MOORE AH, Trentham-Dietz A, Burns M, Gangnon RE, et al
    Obesity and mortality after locoregional breast cancer diagnosis.
    Breast Cancer Res Treat. 2018 Aug 29. pii: 10.1007/s10549-018-4932.
    PubMed     Text format     Abstract available

  19. ZHANG Z, Li C, Fan H, Xiang Q, et al
    Prognostic value of baseline serum HER2 extracellular domain level with a cut-off value of 15 ng/mL in patients with breast cancer: a systematic review and meta-analysis.
    Breast Cancer Res Treat. 2018 Aug 29. pii: 10.1007/s10549-018-4942.
    PubMed     Text format     Abstract available

  20. DE SOUZA TIMOTEO AR, Goncalves AEMM, Sales LAP, Albuquerque BM, et al
    A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer.
    Breast Cancer Res Treat. 2018 Aug 29. pii: 10.1007/s10549-018-4938.
    PubMed     Text format     Abstract available

  21. THOMAS R, Rowell R, Crichton S, Cain H, et al
    Patients electing to have PET rather than surgery for operable breast cancer are a high risk of treatment failure.
    Breast Cancer Res Treat. 2018 Aug 29. pii: 10.1007/s10549-018-4943.
    PubMed     Text format     Abstract available


    Cancer Lett

  22. LOPES R, Korkmaz G, Revilla SA, van Vliet R, et al
    CUEDC1 is a primary target of ERalpha essential for the growth of breast cancer cells.
    Cancer Lett. 2018;436:87-95.
    PubMed     Text format     Abstract available

  23. ZHANG H, Zhang Y, Chen C, Zhu X, et al
    A double-negative feedback loop between DEAD-box protein DDX21 and Snail regulates epithelial-mesenchymal transition and metastasis in breast cancer.
    Cancer Lett. 2018 Aug 27. pii: S0304-3835(18)30539.
    PubMed     Text format     Abstract available

  24. WU Q, Chen D, Luo Q, Yang Q, et al
    Extracellular matrix protein 1 recruits moesin to facilitate invadopodia formation and breast cancer metastasis.
    Cancer Lett. 2018 Aug 27. pii: S0304-3835(18)30540.
    PubMed     Text format     Abstract available


    Cancer Res

  25. YANOVICH G, Agmon H, Harel M, Sonnenblick A, et al
    Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification.
    Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-1079.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  26. RUGO HS, Roche H, Thomas E, Chung HC, et al
    Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30266.
    PubMed     Text format     Abstract available

  27. SPORIKOVA Z, Koudelakova V, Trojanec R, Hajduch M, et al
    Genetic Markers in Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30093.
    PubMed     Text format     Abstract available

  28. SHEEHY EM, Lehane E, Quinn E, Livingstone V, et al
    Information Needs of Patients With Breast Cancer at Years One, Three, and Five After Diagnosis.
    Clin Breast Cancer. 2018 Jun 18. pii: S1526-8209(18)30130.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  29. GUINDALINI RS, Zheng Y, Abe H, Whitaker K, et al
    Intensive surveillance with bi-annual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers.
    Clin Cancer Res. 2018 Aug 28. pii: 1078-0432.CCR-18-0200.
    PubMed     Text format     Abstract available


    Clin Med Insights Oncol

  30. SU YW, Hung CY, Lam HB, Chang YC, et al
    A Single Institution Experience of Incorporation of Cisplatin into Adjuvant Chemotherapy for Patients With Triple-Negative Breast Cancer of Unknown BRCA Mutation Status.
    Clin Med Insights Oncol. 2018;12:1179554918794672.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  31. XIAO W, Zou Y, Zheng S, Hu X, et al
    Primary tumor resection in stage IV breast cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2018 Aug 11. pii: S0748-7983(18)31269.
    PubMed     Text format     Abstract available


    Int J Cancer

  32. YE L, Li F, Song Y, Yu D, et al
    Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of Triple-Negative Breast Cancer.
    Int J Cancer. 2018 Aug 27. doi: 10.1002/ijc.31766.
    PubMed     Text format     Abstract available


    Int J Oncol

  33. WANG H, Xiao Y, Wu L, Ma D, et al
    Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis.
    Int J Oncol. 2018;52:743-754.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  34. MCDUFF SGR, Mina AI, Brunelle CL, Salama L, et al
    Timing of Lymphedema Following Treatment for Breast Cancer: When Are Patients Most At-Risk?
    Int J Radiat Oncol Biol Phys. 2018 Aug 27. pii: S0360-3016(18)33642.
    PubMed     Text format     Abstract available


    J Clin Invest

  35. MABE NW, Fox DB, Lupo R, Decker AE, et al
    Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer.
    J Clin Invest. 2018 Aug 27. pii: 99481. doi: 10.1172/JCI99481.
    PubMed     Text format     Abstract available


    Lancet Oncol

  36. GUNJUR A
    Talazoparib for BRCA-mutated advanced breast cancer.
    Lancet Oncol. 2018 Aug 23. pii: S1470-2045(18)30650.
    PubMed     Text format    


    Mod Pathol

  37. ROSS DS, Zehir A, Brogi E, Konno F, et al
    Immunohistochemical analysis of estrogen receptor in breast cancer with ESR1 mutations detected by hybrid capture-based next-generation sequencing.
    Mod Pathol. 2018 Aug 29. pii: 10.1038/s41379-018-0116.
    PubMed     Text format     Abstract available

  38. LEE M, Heo SH, Song IH, Rajayi H, et al
    Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis.
    Mod Pathol. 2018 Aug 28. pii: 10.1038/s41379-018-0113.
    PubMed     Text format     Abstract available


    NPJ Breast Cancer

  39. MAMOUNAS EP, Russell CA, Lau A, Turner MP, et al
    Clinical relevance of the 21-gene Recurrence Score((R)) assay in treatment decisions for patients with node-positive breast cancer in the genomic era.
    NPJ Breast Cancer. 2018;4:27.
    PubMed     Text format     Abstract available

  40. BLENMAN KRM, He TF, Frankel PH, Ruel NH, et al
    Sentinel lymph node B cells can predict disease-free survival in breast cancer patients.
    NPJ Breast Cancer. 2018;4:28.
    PubMed     Text format     Abstract available


    Oncogene

  41. LEE E, Ouzounova M, Piranlioglu R, Ma MT, et al
    The pleiotropic effects of TNFalpha in breast cancer subtypes is regulated by TNFAIP3/A20.
    Oncogene. 2018 Aug 30. pii: 10.1038/s41388-018-0472.
    PubMed     Text format     Abstract available

  42. GUNTUKU L, Gangasani JK, Thummuri D, Borkar RM, et al
    IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo.
    Oncogene. 2018 Aug 30. pii: 10.1038/s41388-018-0446.
    PubMed     Text format     Abstract available


    Oncol Rep

  43. NUVOLI S, Galassi S, Gelo I, Rocchitta G, et al
    The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy.
    Oncol Rep. 2018;39:2055-2062.
    PubMed     Text format     Abstract available


    Oncology (Williston Park)

  44. SHENG JY, Sharma D, Jerome G, Santa-Maria CA, et al
    Obese Breast Cancer Patients and Survivors: Management Considerations.
    Oncology (Williston Park). 2018;32:410-7.
    PubMed     Text format     Abstract available

  45. ARCIERO C, Thompson P, Meisel JL, Taylor CE, et al
    Multidisciplinary Approaches to Chest Wall Recurrences of Breast Cancer.
    Oncology (Williston Park). 2018;32:392-6.
    PubMed     Text format     Abstract available


    Pathology

  46. LIM JCT, Yeong JPS, Lim CJ, Ong CCH, et al
    An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use.
    Pathology. 2018;50:333-341.
    PubMed     Text format     Abstract available


    PLoS One

  47. BLACKBURN NE, Mc Veigh JG, Mc Caughan EM, Kennedy RD, et al
    The musculoskeletal consequences of latissmus dorsi breast reconstruction in women following mastectomy for breast cancer.
    PLoS One. 2018;13:e0202859.
    PubMed     Text format     Abstract available

  48. KOUSSEMOU M, Lorenz K, Klotz KN
    The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1.
    PLoS One. 2018;13:e0202914.
    PubMed     Text format     Abstract available

  49. SMITH A, Mullooly M, Murphy L, Barron TI, et al
    Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    PLoS One. 2018;13:e0202291.
    PubMed     Text format     Abstract available

  50. COBO-CUENCA AI, Martin-Espinosa NM, Sampietro-Crespo A, Rodriguez-Borrego MA, et al
    Sexual dysfunction in Spanish women with breast cancer.
    PLoS One. 2018;13:e0203151.
    PubMed     Text format     Abstract available

  51. RANASINGHE SL, Boyle GM, Fischer K, Potriquet J, et al
    Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer.
    PLoS One. 2018;13:e0200433.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  52. VEGA-RUBIN-DE-CELIS S, Zou Z, Fernandez AF, Ci B, et al
    Increased autophagy blocks HER2-mediated breast tumorigenesis.
    Proc Natl Acad Sci U S A. 2018;115:4176-4181.
    PubMed     Text format     Abstract available

  53. DE SEMIR D, Bezrookove V, Nosrati M, Dar AA, et al
    PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.
    Proc Natl Acad Sci U S A. 2018 Jun 4. pii: 1804779115.
    PubMed     Text format     Abstract available

  54. MITTAL S, Yeh K, Leslie LS, Kenkel S, et al
    Simultaneous cancer and tumor microenvironment subtyping using confocal infrared microscopy for all-digital molecular histopathology.
    Proc Natl Acad Sci U S A. 2018;115:E5651-E5660.
    PubMed     Text format     Abstract available

  55. SUN X, Wang X, Tang Z, Grivainis M, et al
    Transcription factor profiling reveals molecular choreography and key regulators of human retrotransposon expression.
    Proc Natl Acad Sci U S A. 2018;115:E5526-E5535.
    PubMed     Text format     Abstract available

  56. ZHAO L, Huang S, Mei S, Yang Z, et al
    Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.
    Proc Natl Acad Sci U S A. 2018;115:E3673-E3681.
    PubMed     Text format     Abstract available

  57. ROY B, Venkatachalapathy S, Ratna P, Wang Y, et al
    Laterally confined growth of cells induces nuclear reprogramming in the absence of exogenous biochemical factors.
    Proc Natl Acad Sci U S A. 2018;115:E4741-E4750.
    PubMed     Text format     Abstract available


    Radiology

  58. HYLTON NM
    Residual Disease after Neoadjuvant Therapy for Breast Cancer: Can MRI Help?
    Radiology. 2018 Aug 28:181846. doi: 10.1148/radiol.2018181846.
    PubMed     Text format    

  59. MOY L
    Should We Continue to Biopsy All Amorphous Calcifications?
    Radiology. 2018;288:680-681.
    PubMed     Text format    

  60. ZHANG X, Zheng C, Yang Z, Cheng Z, et al
    Axillary Sentinel Lymph Nodes in Breast Cancer: Quantitative Evaluation at Dual-Energy CT.
    Radiology. 2018 Aug 28:180544. doi: 10.1148/radiol.2018180544.
    PubMed     Text format     Abstract available

  61. WHITMAN GJ, Cantor SB
    Effect of Screening Mammography on Other Preventive Services in Older Women.
    Radiology. 2018 Jun 5:180937. doi: 10.1148/radiol.2018180937.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: